Simplifying Global Compliance
Pfizer Settles FCPA Charges; Sees Leniency Thanks to Proactive Compliance Steps
Washington Drug Letter
Pfizer will pay $60 million to resolve Foreign Corrupt Practices Act charges, but its proactive corporate compliance program allowed it to avoid even harsher penalties — including imposition of an outside corporate monitor.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing